Callio Therapeutics is a biotechnology company focused on developing multi-payload antibody-drug conjugate technology to enhance therapeutic outcomes for cancer patients. By overcoming the limitations of existing single-payload therapies, Callio aims to maximize the therapeutic benefits of its innovative programs.
